CLDX - Celldex Therapeutics Inc Qarzning balans kapitallashuviga nisbati
Celldex Therapeutics (CLDX) kompaniyasining kunlik narxlar grafigi, o'zining maxsus tadqiqotlari qiymati tufayli bozor sikllariga e'tibor bermaydigan, allergiya uchun monoklonal antitelalarni ishlab chiquvchi kompaniyaning biznes barqarorligi ko'rsatkichi bo'lib xizmat qiladi. Joriy ko'rsatkich 0.01 darajasida turibdi. O'z yo'nalishidagi yetakchi mavqei va muvaffaqiyatli sinovlar Celldex Therapeutics (CLDX) kompaniyasiga teri patologiyalarini davolash bo'yicha sug'urta to'lovlari yuzasidan narxlarni belgilash imkoniyatidan foydalanishga imkon beradi.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_CLDX_-_Celldex-Therapeutics_-_Debt-to-Net-Assets-Ratio "Celldex Therapeutics - CLDX Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 27.10.2026) | 👁️GURU.Markets👁️")
Celldex Therapeutics Inc (CLDX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning jamlanma tahliliyoti:Celldex Therapeutics (CLDX)
Yuqori aniqlikdagi mast hujayra retseptorlarini bloklashga investitsiya kiritayotgan Celldex Therapeutics (CLDX) uchun tadqiqot va ishlanmalarni (R&D) moliyalashtirish resurslarining muvozanati hal qiluvchi ahamiyatga ega. GURU.Markets platformasida kitob kapitalizatsiyasiga nisbatan qarz kapitalining ahamiyatini tahlil qilish orqali investor qarzning kapitalga nisbati ko'rsatkichini baholaydi, bunda past ko'rsatkichlar defolt xavfini minimallashtiradi, ammo agressiv ravishda bozor ulushini kengaytirish uchun leverajning yetarli emasligidan dalolat berishi mumkin.
Celldex Therapeutics kimlar bilan raqobatlashadi
Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com (GRFS)|Adaptive Biotechnologies Corporation (ADPT) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Aurinia Pharmaceuticals Inc (AUPH)|Balans kapitallashuviga qarzlar BCRX|Vera Corp - Sof aktivlarga qarzlar|DNTH: Qarzning balans kapitallashuviga nisbati|PHVS: Qarzning balans qiymatiga nisbati|ABCL (AbCellera Corp) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Tourmaline Bio Inc|PGEN (Intrexon) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PHAR|Qarzning balans kapitallashuviga nisbati Nektar Therapeutics NKTR|Qarzning balans qiymatiga nisbati upstreambio.com (UPB)|ZBIO: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Immunome Inc IMNM|GOSS: Balans kapitallashuviga qarzlar|KALV - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar SEPN|PVLA (pieris.com) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Savara|Qarzning balans kapitallashuviga nisbati RIGL|Qarzning balans kapitallashuviga nisbati AnaptysBio Corp (ANAB)|Qarzning balans kapitallashuviga nisbati Astria Corp (ATXS)|ENGN - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati RAPT Therapeutics Inc. RAPT|JBIO (Aerovate) - Balans kapitallashuviga qarzlar|Aclaris Therapeutics Inc. (ACRS) - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Kyverna|Qarzning balans qiymatiga nisbati Tiziana Life Sciences, Ltd.|CABA - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati ventyxbio.com (VTYX)|Qarzning balans qiymatiga nisbati Theratechnologies|Qarzning balans kapitaliga nisbati Avalo Therapeutics, Inc. (AVTX)|Balans kapitallashuviga qarzlar Eledon|Qarzning sof aktivlarga nisbati Agenus, Inc AGEN|CLYM (Climb Bio Inc) - Balans kapitallashuviga qarzlar|ZURA: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati aTyr Pharma ATYR|Adagene Inc. (ADAG) - Qarzning sof aktivlarga nisbati|IMA (ImageneBio) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar STTK|EQ - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati connectbiopharm.com (CNTB)|IMUX: Balans kapitallashuviga qarzlar|ATRA - Balans qiymatiga qarzlar|InflaRx GmbH - Qarzning balans qiymatiga nisbati|X4 Pharmaceuticals, Inc (XFOR) - Balans kapitallashuviga qarzlar|ACET - Qarzning balans qiymatiga nisbati|Celularity (CELU) - Qarzning balans kapitaliga nisbati|INMB: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Barinthus Biotherapeutics PLC|Balans kapitallashuviga qarzlar KZR (Kezar Life Sciences, Inc)|Qarzning balans qiymatiga nisbati SABS (SAB Biotherapeutics Inc)|Qarzning balans kapitallashuviga nisbati AKTX|Sof aktivlarga qarzlar Enlivex Therapeutics Ltd ENLV|QTTB: Balans kapitallashuviga qarzlar|GOVX: Qarzning balans qiymatiga nisbati|Edesa (EDSA) - Qarzning balans kapitallashuviga nisbati|iBio Corporation (IBIO) - Qarzning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar Carisma Therapeutics Inc (CARM)|Qarzning balans qiymatiga nisbati xtlbio.com (XTLB)|Qarzning balans qiymatiga nisbati Bolt Biotherapeutics BOLT|Qarzning balans qiymatiga nisbati HCWB (hcwbiologics.com)|Aptevo Therapeutics Inc. (APVO) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati AIM ImmunoTech, Inc. AIM|Balans kapitallashuviga qarzlar Aditxt Corp (ADTX)|GRI - Qarzning sof aktivlarga nisbati|XRTX: Balans kapitallashuviga qarzlar|HIND (Vyome Holdings Inc.) - Balans kapitallashuviga qarzlar|REVB - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati INDP|Qarzning balans kapitallashuviga nisbati SCNI (Scinai Immunotherapeutics)|Qarzning balans qiymatiga nisbati calcimedica.com (CALI)|Balans kapitallashuviga qarzlar AFMD (Affimed N.V.)|ALLK - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati HOOKIPA (HOOK)|IGMS - Qarzning sof aktivlarga nisbati|iTeos Therapeutics - Balans kapitallashuviga qarzlar|OCEA (oceanbiomedical.com) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati TCBP|Qarzning balans qiymatiga nisbati THRD